TNSN07297A1 - Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetes - Google Patents
Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetesInfo
- Publication number
- TNSN07297A1 TNSN07297A1 TNP2007000297A TNSN07297A TNSN07297A1 TN SN07297 A1 TNSN07297 A1 TN SN07297A1 TN P2007000297 A TNP2007000297 A TN P2007000297A TN SN07297 A TNSN07297 A TN SN07297A TN SN07297 A1 TNSN07297 A1 TN SN07297A1
- Authority
- TN
- Tunisia
- Prior art keywords
- diabetes
- rimonabant
- medicaments
- prevention
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0501861A FR2882261B1 (fr) | 2005-02-21 | 2005-02-21 | Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement du diabete du type 2 |
FR0504942A FR2882264A1 (fr) | 2005-02-21 | 2005-05-12 | Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement du diabete du type 2 |
FR0505228A FR2882265B1 (fr) | 2005-02-21 | 2005-05-23 | Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement du diabete du type 2. |
PCT/FR2006/000376 WO2006087481A1 (fr) | 2005-02-21 | 2006-02-20 | Utilisation du rimonabant pour la preparation de medicaments utiles dans la prevention et le traitement du diabete du type 2 |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN07297A1 true TNSN07297A1 (en) | 2008-12-31 |
Family
ID=36809538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNP2007000297A TNSN07297A1 (en) | 2005-02-21 | 2007-07-31 | Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetes |
Country Status (10)
Country | Link |
---|---|
JP (1) | JP2008530189A (ja) |
BR (1) | BRPI0608183A2 (ja) |
CR (1) | CR9293A (ja) |
EA (1) | EA011618B1 (ja) |
FR (2) | FR2882264A1 (ja) |
IL (1) | IL185401A0 (ja) |
MA (1) | MA29262B1 (ja) |
MX (1) | MX2007009996A (ja) |
TN (1) | TNSN07297A1 (ja) |
TW (1) | TW200640457A (ja) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2789079B3 (fr) * | 1999-02-01 | 2001-03-02 | Sanofi Synthelabo | Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant |
US20040122033A1 (en) * | 2002-12-10 | 2004-06-24 | Nargund Ravi P. | Combination therapy for the treatment of obesity |
-
2005
- 2005-05-12 FR FR0504942A patent/FR2882264A1/fr not_active Withdrawn
- 2005-05-23 FR FR0505228A patent/FR2882265B1/fr not_active Expired - Fee Related
-
2006
- 2006-02-20 JP JP2007555669A patent/JP2008530189A/ja not_active Withdrawn
- 2006-02-20 MX MX2007009996A patent/MX2007009996A/es not_active Application Discontinuation
- 2006-02-20 EA EA200701781A patent/EA011618B1/ru not_active IP Right Cessation
- 2006-02-20 BR BRPI0608183-5A patent/BRPI0608183A2/pt not_active IP Right Cessation
- 2006-02-20 TW TW095105631A patent/TW200640457A/zh unknown
-
2007
- 2007-07-31 TN TNP2007000297A patent/TNSN07297A1/en unknown
- 2007-08-07 CR CR9293A patent/CR9293A/es unknown
- 2007-08-20 IL IL185401A patent/IL185401A0/en unknown
- 2007-08-23 MA MA30158A patent/MA29262B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
FR2882265B1 (fr) | 2009-02-13 |
BRPI0608183A2 (pt) | 2009-11-17 |
CR9293A (es) | 2007-10-01 |
TW200640457A (en) | 2006-12-01 |
MA29262B1 (fr) | 2008-02-01 |
IL185401A0 (en) | 2008-08-07 |
EA011618B1 (ru) | 2009-04-28 |
EA200701781A1 (ru) | 2007-12-28 |
FR2882265A1 (fr) | 2006-08-25 |
MX2007009996A (es) | 2007-10-10 |
FR2882264A1 (fr) | 2006-08-25 |
JP2008530189A (ja) | 2008-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007010560A (es) | Roflumilast para el tratamiento de diabetes mellitus. | |
HK1121074A1 (en) | Treatment of type 2 diabetes with a combination of dpiv inhibitor and metformin or thiazolidinedione | |
GB2430157A (en) | Personal care products and methods for inhibiting the adherence of flora to skin | |
WO2006119958A3 (en) | Use of flibanserin in the treatment of chronic pain | |
MY148723A (en) | Use of pinolenic acid for the treatment of obesity | |
IL185808A0 (en) | Amide-substituted 8-n-benzimidazoles, metohd for the production thereof, and use of the same as medicaments | |
IL186788A0 (en) | Nutritional supplement for hiv patients | |
PL1986669T3 (pl) | Zastosowanie Bifidobacterium longum do zapobiegania i leczenia zapalenia | |
WO2007127273A3 (en) | Methods and compositions for altering cell function | |
WO2006116221A3 (en) | Therapeutic combinations for the treatment or prevention of psychotic disorders | |
WO2007103719A3 (en) | MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME | |
EP2241196A3 (en) | Nutritional supplement comprising oligosaccharides and cysteine for treating hiv | |
EP2091540A4 (en) | PYRAZOLYL DERIVATIVES WITH ANALGETIC EFFECT FOR THE TREATMENT OR PROPHYLAXIS OF PAIN | |
EP1935418A4 (en) | COMPOSITION FOR ALLEVIATING FATIGUE SUBJECTIVE SYMPTOMS | |
EP2164490A4 (en) | PYRAZOLYL DERIVATIVES WITH ANALGESIC PROPERTIES AND THEREFORE USEFUL IN THE TREATMENT OR PROPHYLAXIS OF PAIN | |
WO2008079993A3 (en) | Combinations of nitric oxide and sulfide and methods of use and manufacture thereof | |
TW200728295A (en) | Benzochromene derivatives | |
MX2007011381A (es) | Composicion de espirulinas rica en principios activos, su proceso de obtencion y su utilizacion. | |
WO2007130509A3 (en) | Pyrroloquinoline quinones and use thereof | |
MX2007007355A (es) | 5-(2,2-dimetil-ciclopropil)-3-metil-pen-2-en nitrilo como fragancia y sabor. | |
MY139425A (en) | Pharmaceutical composition comprising 2,4-dichlorobenzyl alcohol and amylmetacresol | |
WO2005105135A8 (en) | Il-6 for therapy or prevention of chemotherapy-induced neuropathy | |
IL185807A0 (en) | Use of amino-substituted benzimidazoles | |
HK1111924A1 (en) | Depigmenting or brightening cosmetic composition comprising at least one oxazolin as an active ingredient | |
RS20050901A (en) | Indole derivatives with apoptosis- inducing effect |